News
Enter your email address to get Core One Labs News Alerts.
Company News
Core One Labs Prepares First in Series of Patent Applications
February 10, 2021
Vancouver, British Columbia, Canada – February 10, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core...
Read more
Company News
Core One Labs Announces Adding Video Conference Capabilities to Teleconference Call Scheduled for February 10, 2021 1:30 p.m. PST/4:30 p.m. EST
February 09, 2021
Vancouver, British Columbia, Canada – February 9, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
Core One Labs Engages Donohoe Advisory for Nasdaq Listing and Schedules Special Investor Call with Dr. Robert E.W. Hancock to Demonstrate Recent Research Outcome
February 06, 2021
Vancouver, British Columbia, Canada – February 6, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) announces that it has engaged Donohoe Advisory Associates...
Read more
Company News
Core One Labs Announces Its Entrance into the Ketamine Space With Proposed Acquisition of Ketamine Infusion Centers of Texas
February 04, 2021
Vancouver, British Columbia, Canada – February 4, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) a biotechnology research...
Read more
Company News
Core One Labs Announces Vocan Assembles Equipment to produce biosynthesized Psilocybin
January 23, 2021
Vancouver, British Columbia, Canada – January 23, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
Core One Labs Completes Sale of Non-Core Assets
January 15, 2021
Vancouver, British Columbia, Canada – January 15, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more